Music Therapy for Pediatric Cancer
Trial Summary
What is the purpose of this trial?
Music therapy has become a standard palliative care service in many pediatric and adult hospitals; however, a majority of music therapy research has focused on the use of music to improve psychosocial dimensions of health, without considering biological dimensions. This study builds on prior work examining the psychosocial mechanisms of action underlying an Active Music Engagement (AME) intervention, designed to help manage emotional distress and improve positive health outcomes in young children with cancer and parents, by examining its effects on biomarkers of stress and immune function. The purposes of this two group, randomized controlled trial are to examine biological mechanisms of effect and dose-response relationships of AME on child/parent stress during the consolidation phase of Acute Lymphoblastic Leukemia (ALL) treatment. Specific aims are to: Aim 1. Establish whether AME lowers child and parent cortisol during ALL treatment. Aim 2. Examine cortisol as a mediator of AME effects on child and parent outcomes during ALL treatment. Aim 3 (exploratory). Examine the dose-response relationship of AME on child and parent cortisol during ALL treatment. Findings will provide a more holistic understanding about how active music interventions work to mitigate cancer-related stress and its potential to improve immune function, with direct implications for the evidence-based use of music to improve health.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it excludes children taking steroid medication for asthma or those with uncontrolled asthma.
What data supports the effectiveness of the treatment Active Music Engagement for pediatric cancer patients?
Is music therapy safe for children with cancer?
How is the Active Music Engagement treatment different from other treatments for pediatric cancer?
Active Music Engagement (AME) is unique because it uses music to help manage emotional distress and improve health outcomes by focusing on both psychosocial and biological aspects, such as stress and immune function, rather than just addressing physical symptoms like many traditional treatments.12348
Eligibility Criteria
This trial is for children aged 3-8 with B- or T-cell acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma, currently in induction therapy. A parent over 18 must attend all sessions. Excluded are children with Ph+ ALL, Cushing disease, certain treatment protocols, uncontrolled asthma, steroid medication for asthma, non-English speaking parents, or significant cognitive impairments.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Consolidation Treatment
Participants receive Active Music Engagement (AME) or attention control during the consolidation phase of ALL treatment. Sessions occur weekly with a focus on reducing stress and improving quality of life.
Follow-up
Participants are monitored for changes in stress biomarkers and quality of life post-treatment.
Treatment Details
Interventions
- Active Music Engagement (Behavioral)
- Audio Storybooks (Behavioral)
Active Music Engagement is already approved in United States, European Union, Canada for the following indications:
- Palliative care for pediatric and adult cancer patients
- Management of emotional distress and stress in young children with cancer and their parents
- Palliative care for cancer patients
- Rehabilitation and stress management in various medical conditions
- Palliative care for cancer patients
- Mental health support and rehabilitation